A preliminary analysis of interleukin-1 ligands as potential predictive biomarkers of response to cetuximab.
Saved in:
| Title: | A preliminary analysis of interleukin-1 ligands as potential predictive biomarkers of response to cetuximab. |
|---|---|
| Authors: | Espinosa-Cotton M; 1Free Radical and Radiation Biology Program, Department of Radiation Oncology, University of Iowa, Iowa City, IA USA.; 2Department of Pathology, 1161 Medical Laboratories, University of Iowa, Iowa City, IA 52242 USA.; 3Holden Comprehensive Cancer Center, University of Iowa Hospitals and Clinics, Iowa City, IA USA., Fertig EJ; 4Division of Biostatistics and Bioinformatics, Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD USA., Stabile LP; 5Department of Pharmacology and Chemical Biology, University of Pittsburgh, Pittsburgh, PA USA., Gaither-Davis A; 5Department of Pharmacology and Chemical Biology, University of Pittsburgh, Pittsburgh, PA USA., Bauman JE; 6Division of Hematology and Oncology, University of Arizona Cancer Center, Tucson, AZ USA., Schmitz S; 7Université catholique de Louvain, Louvain-la-Neuve, Belgium., Gibson-Corley KN; 2Department of Pathology, 1161 Medical Laboratories, University of Iowa, Iowa City, IA 52242 USA.; 3Holden Comprehensive Cancer Center, University of Iowa Hospitals and Clinics, Iowa City, IA USA., Cheng Y; 2Department of Pathology, 1161 Medical Laboratories, University of Iowa, Iowa City, IA 52242 USA.; 8Interdisciplinary Graduate Program in Human Toxicology, University of Iowa, Iowa City, IA USA., Jensen IJ; 2Department of Pathology, 1161 Medical Laboratories, University of Iowa, Iowa City, IA 52242 USA.; 9Interdisciplinary Immunology Graduate Program, University of Iowa, Iowa City, IA USA., Badovinac VP; 2Department of Pathology, 1161 Medical Laboratories, University of Iowa, Iowa City, IA 52242 USA.; 3Holden Comprehensive Cancer Center, University of Iowa Hospitals and Clinics, Iowa City, IA USA.; 9Interdisciplinary Immunology Graduate Program, University of Iowa, Iowa City, IA USA.; 10Department of Microbiology and Immunology, University of Iowa, Iowa City, IA USA., Laux D; 3Holden Comprehensive Cancer Center, University of Iowa Hospitals and Clinics, Iowa City, IA USA.; 11Department of Internal Medicine - Hematology, Oncology and Blood and Marrow Transplantation, University of Iowa Hospitals and Clinics, Iowa City, IA USA., Simons AL; 1Free Radical and Radiation Biology Program, Department of Radiation Oncology, University of Iowa, Iowa City, IA USA.; 2Department of Pathology, 1161 Medical Laboratories, University of Iowa, Iowa City, IA 52242 USA.; 3Holden Comprehensive Cancer Center, University of Iowa Hospitals and Clinics, Iowa City, IA USA.; 8Interdisciplinary Graduate Program in Human Toxicology, University of Iowa, Iowa City, IA USA.; 9Interdisciplinary Immunology Graduate Program, University of Iowa, Iowa City, IA USA. |
| Source: | Biomarker research [Biomark Res] 2019 Jul 16; Vol. 7, pp. 14. Date of Electronic Publication: 2019 Jul 16 (Print Publication: 2019). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: BioMed Central Country of Publication: England NLM ID: 101607860 Publication Model: eCollection Cited Medium: Print ISSN: 2050-7771 (Print) Linking ISSN: 20507771 NLM ISO Abbreviation: Biomark Res Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2050-7771 |
|---|---|
| DOI: | 10.1186/s40364-019-0164-0 |
